Precision Cancer Medicines & Immunotherapy for Lung Cancer
Overview of Lung Cancer
Newsletter Signup | Join Community | Cancer Types
Treatment of multiple myeloma and cancers that spread to bone all benefit from XGEVA treatment.
The precision cancer medicine Enhertu effectively targets HER2 over expressing NSCLC - trials ongoing.
KRAS a major driver of lung and other cancers for KRAS G12C mutated NSCLC - what patients need to know.
Keytruda is the standard of care for PD-1 + NSCLC. Longer follow continues to confirm advantage over chemotherapy.
Tecentriq® Checkpoint Inhibitor immunotherapy improves survival in early and advanced stage non-small cell lung cancers.
FDA Approves Rozlytrek for Treatment of ROS 1 NSCLC
What is the evidence and current recommendations for lung cancer screening - guidelines updated March 2021.
Tarceva™ Improves Survival in Non-Small Cell Lung Cancer
I have small cell lung cancer; radiation to prevent spread to the brain has been recommended…
HER 2 + Lung Cancer Treatment? https://coloradocancerblogs…
Dana Farber and MDACC discover why anti-PD 1 immunotherapy doesnt work in some patients and…
High incidence of ROS 1 false negative tests reported by U Colorado researchers. http://www…